Purchase Order HHSN261201700166P
Award Date 2/23/17
Potential Completion Date 2/28/22
Potential Value $129K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD). The contract is for preventive maintenance services on a BD LSRFortessa 3 laser flow cytometry system with a high-throughput sampler and an additional laser. The contract has a base period of performance from July 1, 2023, through June 30, 2025, with a ceiling value of $132,357.60. This...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for $107,265.00. The contract does not have a set-aside designation. BD is a global medical technology company that provides a range of goods and services to U.S. government agencies, including specialized biomedical equipment, reagents, and laboratory supplies to support research and clinical...
- This is a $700,580.86 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a service maintenance plan for BD LSR Fortessa SORP flow cytometers with high-throughput and BD Influx flow cytometers with lasers. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 9, 2017 without a set-aside designation, indicating BD's...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $402,814.00 firm fixed price purchase order to Becton, Dickinson and Company (BD) for the procurement of a BD LSRFortessa flow cytometer. This was a special order system, and the contract did not have a set-aside designation. BD is a manufacturer and supplier of medical devices, instruments, reagents, and related products to healthcare institutions, clinical laboratories,...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Becton, Dickinson And Company (BD), a global medical technology company. The contract is for the maintenance support of a LSRFORTESSA flow cytometry system, a specialized instrument used in biomedical research and clinical applications. The contract is a firm fixed-price purchase order with a potential value of $126,944.40 and a...
- This is a firm-fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for an annual maintenance agreement on LSR Fortessa, CytoFLEX, and high-throughput sampler instruments. The potential value of the contract is $32,288.48 and the performance period is from February 1, 2019 to January 31, 2020. The contract was not set aside for any specific...
- This federal contract award, with an ID of HHSN261201600702P, was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Becton, Dickinson and Company (BD) for the maintenance services of a BD Biosciences FACSAria Fusion Special Order (SORP) flow cytometry cell sorter system, including two lasers, three additional lasers, one computer workstation, and a custom-tailored biosafety cabinet. The $139,199.34 firm fixed-price purchase...
- This is a $126,090.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Becton, Dickinson and Company (BD) for a service contract to provide an LSRFortessa flow cytometer with lasers. The contract does not have a set-aside designation. BD, a large medical technology and manufacturing company, will deliver the flow cytometry instrument to support research activities at the NIH...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a purchase order to Becton, Dickinson and Company, operating through its IDS division (doing business as BD Diagnostic Systems), for the maintenance of a government-owned BD LSRII flow cytometry system. The firm-fixed-price contract has a potential value of $101,685.60 and a completion date of June 5, 2022. The contract does not have a set-aside designation. Becton, Dickinson and Company...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for the upgrade and installation of LSR Fortessa detectors. The contract has a ceiling value of $7,275.00 and a completion date of March 25, 2016. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications. This contract is related to BD's BD Biosciences...